Journey Medical (DERM) EBIAT (2020 - 2025)
Historic EBIAT for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to -$2.3 million.
- Journey Medical's EBIAT rose 313.81% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.7 million, marking a year-over-year increase of 5275.41%. This contributed to the annual value of -$14.7 million for FY2024, which is 28079.42% down from last year.
- Latest data reveals that Journey Medical reported EBIAT of -$2.3 million as of Q3 2025, which was up 313.81% from -$3.8 million recorded in Q2 2025.
- In the past 5 years, Journey Medical's EBIAT ranged from a high of $16.8 million in Q3 2023 and a low of -$21.8 million during Q4 2021
- Moreover, its 5-year median value for EBIAT was -$4.1 million (2025), whereas its average is -$5.4 million.
- In the last 5 years, Journey Medical's EBIAT plummeted by 3681034.48% in 2021 and then skyrocketed by 26655.75% in 2023.
- Journey Medical's EBIAT (Quarter) stood at -$21.8 million in 2021, then soared by 51.07% to -$10.6 million in 2022, then skyrocketed by 79.86% to -$2.1 million in 2023, then surged by 170.98% to $1.5 million in 2024, then crashed by 252.2% to -$2.3 million in 2025.
- Its EBIAT was -$2.3 million in Q3 2025, compared to -$3.8 million in Q2 2025 and -$4.1 million in Q1 2025.